(Q53352965)

13 May 2018

title

Alpha2-macroglobulin deletion polymorphism and plasma levels in late onset Alzheimer's disease. (English)

1 reference

13 May 2018

0 references

Renato Scacchi

1

1 reference

13 May 2018

Maria Ruggeri

2

1 reference

13 May 2018

Giuseppe Gambina

3

1 reference

13 May 2018

Maria C Martini

4

1 reference

13 May 2018

Rosa M Corbo

5

1 reference

13 May 2018

publication date

1 April 2002

1 reference

13 May 2018

Clinical Chemistry and Laboratory Medicine

published in

1 reference

13 May 2018

volume

40

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

333-336

1 reference

13 May 2018

Alpha-2 macroglobulin is genetically associated with Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.052

Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.052

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.052

A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.052

Alpha-2-macroglobulin intronic polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.052

Relationship between serum alpha 1-antichymotrypsin and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.052

Serum alpha 1-antichymotrypsin level as a marker for Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.052

Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.052

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.052

No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.052

21 January 2018

Identifiers

DOI

10.1515/CCLM.2002.052

1 reference

13 May 2018

1 reference

13 May 2018